|
1
|
la Rosa AH, Acker M, Swain S and Manoharan
M: The role of epigenetics in kidney malignancies. Cent European J
Urol. 68:157–164. 2015.PubMed/NCBI
|
|
2
|
Klatte T, Pantuck AJ, Riggs SB, Kleid MD,
Shuch B, Zomorodian N, Kabbinavar FF and Belldegrun AS: Prognostic
factors for renal cell carcinoma with tumor thrombus extension. J
Urol. 178:1189–1195. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Liu B, Wen X and Cheng Y: Survival or
death: Disequilibrating the oncogenic and tumor suppressive
autophagy in cancer. Cell Death Dis. 4:e8922013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Criscitiello C, Esposito A and Curigliano
G: Tumor-stroma crosstalk: Targeting stroma in breast cancer. Curr
Opin Oncol. 26:551–555. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Sato H, Hagiwara H, Ohde Y, Senba H,
Virgona N and Yano T: Regulation of renal cell carcinoma cell
proliferation, invasion and metastasis by connexin 32 gene. J Membr
Biol. 216:17–21. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Paoli P, Giannoni E and Chiarugi P:
Anoikis molecular pathways and its role in cancer progression.
Biochim Biophys Acta. 1833:3481–3498. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Strauss SJ, Ng T, Mendoza-Naranjo A,
Whelan J and Sorensen PH: Understanding micrometastatic disease and
Anoikis resistance in ewing family of tumors and osteosarcoma.
Oncologist. 15:627–635. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zheng H, Guo X, Tian Q, Li H and Zhu Y:
Distinct role of Tim-3 in systemic lupus erythematosus and clear
cell renal cell carcinoma. Int J Clin Exp Med. 8:7029–7038.
2015.PubMed/NCBI
|
|
9
|
Zhou E, Huang Q, Wang J, Fang C, Yang L,
Zhu M, Chen J, Chen L and Dong M: Up-regulation of Tim-3 is
associated with poor prognosis of patients with colon cancer. Int J
Clin Exp Pathol. 8:8018–8027. 2015.PubMed/NCBI
|
|
10
|
Piao YR, Jin ZH, Yuan KC and Jin XS:
Analysis of Tim-3 as a therapeutic target in prostate cancer.
Tumour Biol. 35:11409–1480. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan J, Jiang B, Zhao H and Huang Q:
Prognostic implication of TIM-3 in clear cell renal cell carcinoma.
Neoplasma. 61:35–40. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sakamoto S, Schwarze S and Kyprianou N:
Anoikis disruption of focal adhesion-Akt signaling impairs renal
cell carcinoma. Eur Urol. 59:734–744. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Li L, Jiang AC, Dong P, Wang H, Xu W and
Xu C: MDR1/P-gp and VEGF synergistically enhance the invasion of
Hep-2 cells with multidrug resistance induced by taxol. Ann Surg
Oncol. 16:1421–1428. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang YQ and Chen J: Predictive role of
vascular endothelial growth factor polymorphisms in the survival of
renal cell carcinoma patients. Genet Mol Res. 13:5011–5017. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Cai C, Wang L, Wu Z, Li M, Chen W and Sun
Y: T-cell immunoglobulin- and mucin-domain-containing molecule 3
gene polymorphisms and renal cell carcinoma. DNA Cell Biol.
31:1285–1289. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Komohara Y, Morita T, Annan DA, Horlad H,
Ohnishi K, Yamada S, Nakayama T, Kitada S, Suzu S, Kinoshita I, et
al: The coordinated actions of TIM-3 on cancer and myeloid cells in
the regulation of tumorigenicity and clinical prognosis in clear
cell renal cell carcinomas. Cancer Immunol Res. 3:999–1007. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Dannenmann SR, Thielicke J, Stöckli M,
Matter C, von Boehmer L, Cecconi V, Hermanns T, Hefermehl L,
Schraml P, Moch H, et al: Tumor-associated macrophages subvert
T-cell function and correlate with reduced survival in clear cell
renal cell carcinoma. Oncoimmunology. 2:e235622013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hamed HA, Das SK, Sokhi UK, Park MA,
Cruickshanks N, Archer K, Ogretmen B, Grant S, Sarkar D, Fisher PB
and Dent P: Combining histone deacetylase inhibitors with
MDA-7/IL-24 enhances killing of renal carcinoma cells. Cancer Biol
Ther. 14:1039–1049. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee HW, Joo KM, Lim JE, Cho HJ, Cho HJ,
Park MC, Seol HJ, Seo SI, Lee JI, Kim S, et al: Tpl2 kinase impacts
tumor growth and metastasis of clear cell renal cell carcinoma. Mol
Cancer Res. 11:1375–1386. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Takaha N, Sowa Y, Takeuchi I, Hongo F,
Kawauchi A and Miki T: Expression and role of HMGA1 in renal cell
carcinoma. J Urol. 187:2215–2222. 2012. View Article : Google Scholar : PubMed/NCBI
|
